W.R. Berkley Corp’s Kite Pharma, Inc. KITE Stock Holding History

W.R. Berkley Corp’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,500	Closed	-$4.05M	–	121
2017 Q3	$4.05M	Buy	+22,500	New	+$3.14M	0.54%	33

W.R. Berkley Corp's KITE Position: Q4 2017 in Review

W.R. Berkley Corp sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 22,500 shares — an estimated $4.05M sold.

W.R. Berkley Corp first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $4.05M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

W.R. Berkley Corp reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
W.R. Berkley Corp sold 22,500 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.05M.
W.R. Berkley Corp first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
W.R. Berkley Corp's Kite Pharma, Inc. position peaked at $4.05M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on W.R. Berkley Corp's 13F filing for Q4 2017, filed 14 Feb 2018.